@misc{indiciae3ffecbc1622b,
  title = {A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to known RBD mutations},
  author = {Bertoglio, F. and Fühner, V. and Ruschig, M. and Heine, P. A. and Rand, U. and Klünemann, T. and Meier, D. and Langreder, N. and Steinke, S. and Ballmann, R. and Schneider, K.-T. and Roth, K. D. R. and Kuhn, P. and Riese, P. and Schäckermann, D. and Korn, J. and Koch, A. and Zock-Emmenthal, S. and Becker, M. and Scholz, M. and Moreira, G. M. S. G. and Wenzel, E. V. and Russo, G. and Garritsen, H. S. P. and Casu, S. and Gerstner, A. and Roth, G. and Hermann, A. and Schirrmann, T. and Dübel, S. and Frenzel, A. and Van den Heuvel, J. and Cicin-Sain, L. and Schubert, M. and Hust, M.},
  year = {2020},
  doi = {10.1101/2020.12.03.409318},
  url = {https://www.biorxiv.org/content/10.1101/2020.12.03.409318v1},
  note = {Source identifier: 10.1101/2020.12.03.409318}
}